Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes.
Smith SG, Foy R, McGowan JA, Kobayashi LC, DeCensi A, Brown K, Side L, Cuzick J.

What influences healthcare professionals' treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment.
Morgan JL, Walters SJ, Collins K, Robinson TG, Cheung KL, Audisio R, Reed MW, Wyld L.

Assessment of lead-time bias in estimates of relative survival for breast cancer.
Andersson TM, Rutherford MJ, Humphreys K.

Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer.
Page K, Guttery DS, Fernandez-Garcia D, Hills A, Hastings RK, Luo J, Goddard K, Shahin V, Woodley-Barker L, Rosales BM, Coombes RC, Stebbing J, Shaw JA.

TAp73 upregulates IL-1β in cancer cells: Potential biomarker in lung and breast cancer?
Vikhreva P, Petrova V, Gokbulut T, Pestlikis I, Mancini M, Di Daniele N, Knight RA, Melino G, Amelio 

This NHS project is an excellent opportunity for patients with rare conditions (including some congenital heart conditions), and certain cancers, and their families, to obtain a genetic diagnosis by genomic sequencing. It aims to sequence 100,000 genomes from NHS patients by 2018. More information here.  

UHL project members have produced “Eligibility Wheels” as a simple guide to help clinicians identify potential participants to join the 100,000 Genomes Project.   The wheels bring together conditions that would be seen by a physician in a clinic setting. They can be displayed in clinical areas where most useful, such as on consultation room noticeboards or in toggled booklets.  You can download the Eligibility Wheels from the following link: https://www.genomicseducation.hee.nhs.uk/taught-courses/eligibility-wheels-library/ .  

If you have any further enquiries, please contact the Leicester recruitment team via email: genomesproject@uhl-tr.nhs.uk  or by telephone on: 0116 258 6968.